Top 50 Health Care Startup Investors in Finland (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Business Finland
VC Fund
|
23 | Finland, United States, Sweden | Grant, Seed, Debt Financing | Software, SaaS, Biotechnology | $50k–$10M |
|
Butterfly Ventures
VC Fund
|
20 | Finland, Sweden, Norway | Seed, Pre-Seed | Software, Health Care, Information Technology | $110k–$4.3M |
|
Lifeline Ventures
VC Fund
|
19 | Finland, United States, United Kingdom | Seed, Series A, Venture - Series Unknown | Software, Health Care, Artificial Intelligence | $430k–$22M |
|
Tesi
VC Fund
|
18 | Finland, United States, Switzerland | Series A, Series B | Software, Manufacturing, Information Technology | $2.4M–$46M |
|
Finnvera Venture Capital
VC Fund
|
16 | Finland, United States, Chile | Seed, Series A | Software, Health Care, Manufacturing | $250k–$23M |
|
Innovestor
VC Fund
|
15 | Finland, Sweden, Denmark | Seed, Venture - Series Unknown, Pre-Seed | Software, Health Care, Information Technology | $204k–$5.1M |
|
Voima Ventures
VC Fund
|
14 | Finland, Sweden, Norway | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Artificial Intelligence | $464k–$30M |
|
Icebreaker.vc
VC Fund
|
14 | Finland, Sweden, Estonia | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | $110k–$25M |
|
Springvest
VC Fund
|
9 | Finland | Series A, Venture - Series Unknown, Seed | Biotechnology, Health Care, Medical | $1.6M–$53M |
|
Ali Omar
Angel
|
9 | Finland, United States, Estonia | Seed, Pre-Seed, Angel | Software, Artificial Intelligence, SaaS | $57k–$2.2M |
|
Inventure
VC Fund
|
9 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $549k–$25M |
|
Reaktor Ventures
VC Fund
|
8 | Finland, Germany, United States | Seed, Pre-Seed, Series A | Software, Internet, E-Commerce | $137k–$6.8M |
|
StartUp Health
VC Fund
|
8 | United States, Canada, United Kingdom | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Medical, Wellness | $20k–$15M |
|
Redstone.VC
VC Fund
|
7 | Germany, Finland, Switzerland | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $460k–$17M |
|
Nordic Science Investments
VC Fund
|
6 | Finland, Sweden, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $373k–$34M |
|
Almaral
VC Fund
|
5 | Finland | Seed, Convertible Note, Venture - Series Unknown | Medical Device, Health Diagnostics, Software | $832k–$2.9M |
|
Visionplus
VC Fund
|
5 | Finland, United States, United Kingdom | Seed, Venture - Series Unknown, Series A | Software, Information Technology, Internet | $83k–$14M |
|
Leena Niemistö
Angel
|
5 | Finland, United States | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Software, E-Commerce | $306k–$3.5M |
|
VTT Ventures
VC Fund
|
5 | Finland | Seed, Venture - Series Unknown, Series A | Manufacturing, Biotechnology, Electronics | $460k–$14M |
|
University of Helsinki
VC Fund
|
4 | Finland, Luxembourg, United States | Seed, Series A, Pre-Seed | Medical, Health Care, Biotechnology | $54k–$34M |
|
Nidoco
VC Fund
|
4 | Finland, Sweden, Estonia | Seed, Venture - Series Unknown, Pre-Seed | Software, SaaS, Artificial Intelligence | $327k–$60M |
|
Sitra
VC Fund
|
4 | Finland, The Netherlands | Venture - Series Unknown, Grant | Health Care, Biotechnology, CleanTech | $1.5M–$3.4M |
|
Stefan Lindberg
Angel
|
4 | Finland | Pre-Seed, Seed, Angel | Wellness, Nutrition, Fruit | $179k–$549k |
|
Novo Holdings
VC Fund
|
4 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.5M–$135M |
|
Antler
VC Fund
|
4 | United States, Singapore, Australia | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
Maki.vc
VC Fund
|
4 | Finland, Norway, Denmark | Seed, Series A, Pre-Seed | Software, E-Commerce, Information Technology | $578k–$37M |
|
Superhero Capital
VC Fund
|
4 | Finland, Lithuania, Estonia | Seed, Pre-Seed, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $114k–$7.3M |
|
Oy Hammaren & Co Ab
VC Fund
|
4 | Finland | Venture - Series Unknown, Angel, Series A | Health Care, Wellness, GreenTech | $1.5M–$7.8M |
|
Novartis Venture Fund
VC Fund
|
4 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5.1M–$107M |
|
Johannes Schildt
Angel
|
3 | Sweden, Finland, United States | Seed, Pre-Seed, Series A | Health Care, Software, Artificial Intelligence | $641k–$18M |
|
Elias Aalto
Angel
|
3 | Finland, Sweden, Estonia | Seed, Pre-Seed, Series A | Internet, Health Care, Information Technology | $430k–$10M |
|
M Ventures
VC Fund
|
3 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
Cascara Ventures
VC Fund
|
3 | Germany, Finland, The Netherlands | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $2M–$7.9M |
|
EISMEA
VC Fund
|
3 | Spain, Italy, United Kingdom | Grant, Venture - Series Unknown, Seed | Manufacturing, Software, Biotechnology | $53k–$2.6M |
|
Gorilla Capital
VC Fund
|
3 | Finland, Sweden, Estonia | Pre-Seed, Seed, Venture - Series Unknown | Software, Information Technology, SaaS | $149k–$2.1M |
|
Karolinska
VC Fund
|
3 | Sweden, Denmark, United States | Venture - Series Unknown, Seed | Biotechnology, Health Care, Pharmaceutical | $3.2M–$10M |
|
Kustaa Piha
Angel
|
3 | Finland | Seed, Venture - Series Unknown | Health Care, Health Diagnostics, Medical Device | $537k–$1.3M |
|
Apteekkien Eläkekassa
VC Fund
|
3 | Finland | Venture - Series Unknown | Health Care | |
|
Pontos Group
VC Fund
|
3 | Finland, Estonia | Venture - Series Unknown, Seed | Apps, Mobile, Content | $6.3M–$16M |
|
European Investment Bank
VC Fund
|
3 | France, Germany, Spain | Debt Financing, Post-IPO Debt, Venture - Series Unknown | Biotechnology, Energy, Health Care | $8.7M–$587M |
|
Jyri Engestrom
Angel
|
3 | United States, Finland, Spain | Seed, Pre-Seed, Series A | Software, Apps, Internet | $600k–$20M |
|
Lynx Capital
VC Fund
|
3 | Finland, United States | Series A, Venture - Series Unknown, Seed | Health Care, Medical, Biotechnology | |
|
Athensmed
VC Fund
|
3 | Finland, Switzerland | Seed, Series A | Health Care, Health Diagnostics, Medical | $1.1M–$4.3M |
|
First Fellow Partners
VC Fund
|
3 | Finland, United States, Sweden | Seed, Series A, Pre-Seed | Software, SaaS, Information Technology | $256k–$26M |
|
Cor Group
VC Fund
|
3 | Finland | Seed, Pre-Seed, Series A | Health Care, Medical, Biotechnology | $2.3M–$8.7M |
|
HealthCap
VC Fund
|
3 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $6M–$92M |
|
Nostetta Ventures
VC Fund
|
3 | Finland | Seed, Pre-Seed | Health Care, Medical Device | $1.1M–$2.9M |
|
Creathor Ventures
VC Fund
|
2 | Germany, Switzerland, United States | Series A, Series B, Seed | Software, Health Care, Biotechnology | $1.1M–$30M |
|
Alliance VC
VC Fund
|
2 | Norway, United States, Sweden | Seed, Series A, Pre-Seed | Software, Information Technology, Analytics | $1M–$19M |
|
Metsola Ventures
VC Fund
|
2 | Finland | Series A | Medical, mHealth, Health Care | $2.2M–$4.8M |
| Access all 423 investors in Finland Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more...Investment focus
- Industry: Software, SaaS, Biotechnology
- Stage:Grant, Seed, Debt Financing
- Geography: Finland, United States, Sweden
Investor stats
- Total investments: 238
- Round size: Seed $334k–$3.5M; Grant $50k–$10M; Debt Financing $252k–$6.5M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- STRGY AI — The strategy was never the problem. The evidence was correct, sitting in someone's hands, and it died anyway because nothing in the organization was built to carry that evidence from where it was seen to where it could be acted on, and keep it alive long enough to matter. Not a bad plan. Not bad people. A structural gap between signal andauthority that every existing tool — decks, dashboards, status meetings — is too static and too easy to ignore to actually close.STRGY exists because that gap is the default state of every organization above a certain size, and closing it has always required either a heroic individual repeating themselves for years or luck (the corporate pilot needed one person to remember "do not drop this" at the right moment, and no one did). That's not a strategy problem to solve with a better framework — it's an infrastructure problem. You need something that holds the signal, doesn't forget it, doesn't get bored repeating it, and resurfaces it automatically the moment the gap between evidence and action starts to widen. That's what a human can't do reliably at scale, and what software with real memory can.
- Coolbrook — Our RotoDynamic electric technology can cut 30% of industrial emissions annually, delivering hope at industrial scale.
- Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 91
- Round size: Seed $224k–$2.2M; Pre-Seed $110k–$4.3M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $49M in 2022
Portfolio highlights
- DREV — DREV is a cleantech company manufacturing contamination control solutions for the world’s most advanced manufacturing facilities.
- Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
- Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 203
- Round size: Seed $580k–$5.4M; Series A $2.8M–$22M; Venture - Series Unknown $430k–$17M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fresh fund, raised $464M in 2025
Portfolio highlights
- Verda — Verda provides a full-stack AI cloud platform for the development, training, and deployment of AI models.
- S-Transistors — S-Transistors is one of the few businesses founded on a truly novel core technology that has the potential to serve as an enabling layer for a whole industry.
- Thor Dynamics — Directed Energy Systems for Counter-Drone Defense
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Series B
- Geography: Finland, United States, Switzerland
Investor stats
- Total investments: 154
- Round size: Series A $2.4M–$46M; Series B $3.1M–$40M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $177M in 2017
Portfolio highlights
- Vexlum — A #laser company providing high-power #VECSELs for #QuantumTechnology
- Verda — Verda provides a full-stack AI cloud platform for the development, training, and deployment of AI models.
- Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Finland, United States, Chile
Investor stats
- Total investments: 95
- Round size: Seed $250k–$2.3M; Series A $1.8M–$23M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
- eMabler — EMabler is an EV charging infrastructure software company that develops an API-first platform used by businesses to operate, manage, and scale electric vehicle charging networks. It provides a centralized system for charge point management, billing, pricing, roaming, and energy optimization, allowing operators to control large networks of EVchargers from a single platform. The software connects charging hardware with business systems such as CRM, payment, and energy management tools through open APIs and a large library of integrations. The company focuses on enabling enterprises, such as energy utilities, parking operators, and retail businesses, to embed EV charging directly into their existing services and digital platforms rather than building standalone charging systems. This includes white-label solutions where charging is integrated into a company’s own app or customer experience under its brand.
- CHAOS — At CHAOS, we strive to democratize data and harness the power of AI and cutting-edge technology, delivering transformative location insights that empower decision-makers to design more liveable cities- sustainable, human-centered where the quality-of-life soars.
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Finland, Sweden, Denmark
Investor stats
- Total investments: 97
- Round size: Seed $477k–$4.5M; Pre-Seed $204k–$2M; Venture - Series Unknown $529k–$5.1M
- Lead/follow: 56% lead, 44% follow
- Last fund: Likely still investing — raised $33M in 2023
Portfolio highlights
- Khoy — Khoy Company designs and develops comfortable, user-friendly, and sustainable sofa beds.
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 61
- Round size: Seed $1M–$5.9M; Pre-Seed $464k–$2.1M; Series A $3.9M–$30M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely still investing — raised $108M in 2023
Portfolio highlights
- Reduciner — Reduciner's vision to turn industrial CO₂ emissions from a liability into a valuable resource. Its technology converts captured carbon dioxide and biochar into valuable feedstocks such as carbon monoxide and activated carbon, enabling circular carbon use in emissions-intensive industries. Reduciner combines strong scientific expertise withindustrial applicability across sectors such as cement, steel, and chemicals. Its electricity-driven process allows industries to reduce emissions without major changes to existing infrastructure, offering a resilient and cost-competitive way to reduce carbon dependency while creating new value from CO₂ emissions.
- TheStorage — Flexible industrial heat electrification and scalable energy storage. TheStorage offers cost efficient, sustainable grid scale energy storage that can discharge heat, steam or CHP.
- Photoncycle — The year-round solar energy system for heating and electricity
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Finland, Sweden, Estonia
Investor stats
- Total investments: 143
- Round size: Seed $409k–$5.4M; Pre-Seed $110k–$1.3M; Series A $3.1M–$25M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — raised $24M in 2021
Portfolio highlights
- Cytely — Cytely operationalizes biological measurement, turning microscopy into standardized, reproducible data so research teams can accelerate discovery.
- Oplane — Connect your repo. See and fix your vulnerabilities in minutes. AI-powered threat modeling - no consultants, no weeks of docs.
- Cota Robotics — Cota Robotics deploys general-purpose robots in retail stores through a Robot-as-a-Service model, integrating with existing environments without requiring changes to store layouts or infrastructure. The company automates shelf replenishment, inbound handling, and order picking using human-in-the-loop teleoperation, with autonomy increasing asdeployment data trains its models.
The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Finland
Investor stats
- Total investments: 23
- Round size: Seed $1.6M–$7.6M; Series A $3.6M–$53M; Venture - Series Unknown $4.7M–$29M
- Lead/follow: 74% lead, 26% follow
Portfolio highlights
- ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
- MedicubeX — MedicubeX aims to revolutionize preventive healthcare by building a network of autonomous self-measurement and telehealth eHealth Stations. We are the most advanced health kiosk and the first one in the Nordics. The eHealth Station offers regular clinical-grade medical check-ups for everyone regardless of location.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
Ali Omar is a Member of the Finnish Business Angels Network. He attended Aalto University and the University of Oulu.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Angel
- Geography: Finland, United States, Estonia
Investor stats
- Total investments: 69
- Round size: Seed $227k–$2.2M; Angel $57k–$1.7M; Pre-Seed $168k–$734k
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Themo — Themo's innovation is an algorithm that optimizes the price of exchange electricity and the consumption of electricity. Themo offers an easy and environmentally friendly way to save on electricity consumed by heating.
- GoalProfit — GoalProfit is the world’s first low code retail optimization platform empowering retailers to build customized intelligence applications. It was founded by former IBM executives, Maxim Morozov and Oleg Sidorkin. GoalProfit is on a mission to make big data solutions available for all retailers and help them to survive in a new post-covid reality.
- Retailgrid — Agentic AI pricing platform for mid-market retailers. Turn messy retail data into structured, explainable price decisions in days, not months.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 180
- Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$25M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $140M in 2022
Portfolio highlights
- Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
- Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
- Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Reaktor Ventures they invest in seed stage companies and helps them to create markets.
Show more...Investment focus
- Industry: Software, Internet, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Germany, United States
Investor stats
- Total investments: 60
- Round size: Seed $137k–$2.1M; Pre-Seed $158k–$1.8M; Series A $1.7M–$6.8M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
- allies.digital — Allies is a match-making platform curating businesses with IT-, digital and creative agencies. No more miss-matches when buying IT & creative services.
- StarBerry Games — StarBerry Games GmbH is a mobile games company based in Berlin, Germany. The company develops free-to-play casual mobile games and is best known for its games Merge Mayor and Idle Coffee Corp.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Medical, Wellness
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 361
- Round size: Seed $100k–$4M; Pre-Seed $20k–$854k; Venture - Series Unknown $150k–$15M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $31M in 2018
Portfolio highlights
- AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
- Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Finland, Switzerland
Investor stats
- Total investments: 179
- Round size: Seed $460k–$7.8M; Pre-Seed $1M–$4.4M; Series A $1.7M–$17M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fresh fund, raised $29M in 2026
Portfolio highlights
- FermLabs — Ferm Labs ingredient startup specializing in proprietary, high-yield bioprocessing platforms.
- LimX Dynamics — Zhuji Dynamics is a general-purpose footed robot company that focuses on the R&D and manufacturing of sports intelligence and footed robots
- Zhuji Dynamics — Zhuji Dynamics is a general-purpose footed robot company that focuses on the R&D and manufacturing of sports intelligence and footed robots
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 18
- Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$34M
- Lead/follow: 83% lead, 17% follow
- Last fund: Likely still investing — raised $34M in 2024
Portfolio highlights
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- mu-ray.tech — MuRay Tech generates a controlled muon beam to image inside solid metal and 3D printed pieces. Non-destructively. In minutes.
- Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
Almaral provides risk management advice long-term strategy development budgeting operational function setup legal support early-stage sales and marketing function setup, and commercialization.
Show more...Investment focus
- Industry: Medical Device, Health Diagnostics, Software
- Stage:Seed, Convertible Note, Venture - Series Unknown
- Geography: Finland
Investor stats
- Total investments: 6
- Round size: Seed $832k–$2.9M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Fepod — Fepod Oy Ltd develops a point-of-care diagnostics platform for rapid blood concentration measurement of pain medicine and other markers. Using a mobile phone, portable reader, and disposable sensors, it delivers quick, accurate results in minutes, enabling timely treatment decisions in acute care settings. The company aims to be the #1 acute carePOC diagnostics platform by 2030.
- Marginum — Pioneering the next-generation quantitative surgical techniques.
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
WE HELP YOU TO GROW FASTER!
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 75
- Round size: Seed $83k–$1.3M; Series A $2M–$14M; Venture - Series Unknown $100k–$4M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- SingOn — SingOn is an on-demand karaoke service for PlayStation 3. It aims to modernize singing games by developing a clean and modern interface design. SingOn’s dynamic streaming services allow its developers to launch with thousands of songs and to update the game every week with new tracks.SingOn provides its users with a wide variety of songs and isconstantly updated with more songs, including songs from the UK Top 20 Charts. It was launched in 2009 by Risto Valkola and Samu Keränen.
- LiveMusicStage — We're a live music venue online. We let you to actually take part in the shows and interact with the bands while they're playing. You're always in the front row
- Logonet promotion — Logonet was established in 1992 in Finland and has since grown to a company with offices in nine countries and three continents.
Leena Niemistö
Show more...Investment focus
- Industry: Health Care, Software, E-Commerce
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Finland, United States
Investor stats
- Total investments: 19
- Round size: Seed $306k–$3.2M; Venture - Series Unknown $2.2M–$3.5M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Rens Original — RENS Original is the World's First Sneaker made from recycled coffee and plastic. We know you've been drinking it, now it is time to wear it.
- Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Electronics
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Finland
Investor stats
- Total investments: 24
- Round size: Seed $460k–$3.3M; Series A $1.8M–$14M; Venture - Series Unknown $1.5M–$9.2M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
- Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
- Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
The University of Helsinki has the widest range of disciplines in Finland. It was established in Turku in 1640, but was transferred to Helsinki in 1828. The number of faculties is eleven. There are 35,000 degree students and 7,900 staff. The number of degrees taken each year is an average 5,000, of which about 470 are doctorates. The Universityconcentrates on high-level scientific research and researcher education. Scientific research is also the basis of the teaching provided by the University. The University operations support the development of society, as well as business and industry. University representatives offer their competencies for the benefit of society through a number of positions of trust and expertise. The results produced by the research and teaching carried out at the University have been widely acclaimed. The University participates in more than half of the national Centres of Excellence in Research, elected by international scientific panels. The University of Helsinki has been invited to be a member of the League of European Research Universities, a co-operation body for the leading European research universities. According to international expert panels, also the teaching provided by the University of Helsinki is of a high European level. The University has strong international connections. It has some 80 co-operation agreements with universities on different continents. The University researchers are in great demand as experts in international scientific communities, meetings and publications. The University is bilingual, but in addition to Finnish and Swedish teaching is also provided in English. Besides Helsinki, the University has operations at 20 localities throughout Finland.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, Luxembourg, United States
Investor stats
- Total investments: 12
- Round size: Seed $54k–$7.4M; Pre-Seed $837k–$1.2M; Series A $2.9M–$34M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Ferrivia — Ferrivia on suomalainen palvelu, joka keskittyy raudanpuutteen ja rautaterveyden mittaamiseen.
- Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
- Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Nidoco AB is a Swedish investment company whose strategy is to create long-term value through active ownership of public and private companies.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Finland, Sweden, Estonia
Investor stats
- Total investments: 29
- Round size: Seed $327k–$2.6M; Pre-Seed $700k–$759k; Venture - Series Unknown $1.5M–$60M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Betolar — Betolar is a materials technology company that develops circular economy solutions for the mining, metals, and construction sectors by transforming industrial sidestreams and waste materials into valuable products. Its technologies support the production of low-carbon, cement-free construction materials and enable the recovery of critical andstrategic metals from industrial waste streams. The company provides material analysis, consulting, and recipe optimization services, utilizing digitalization, data platforms, and artificial intelligence to support research, development, and industrial applications. Betolar's solutions are designed to help reduce carbon emissions, decrease reliance on virgin raw materials, and improve the utilization of industrial byproducts. Its activities span construction materials, metal extraction technologies, and circular material solutions that support more resource-efficient industrial processes.
- TactoTek — Set your imagination free and create user experiences with the help of sustainable smart molded structures.
- CHAOS — At CHAOS, we strive to democratize data and harness the power of AI and cutting-edge technology, delivering transformative location insights that empower decision-makers to design more liveable cities- sustainable, human-centered where the quality-of-life soars.
Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, CleanTech
- Stage:Venture - Series Unknown, Grant
- Geography: Finland, The Netherlands
Investor stats
- Total investments: 9
- Round size: Venture - Series Unknown $1.5M–$3.4M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- Headai — We help organizations succeed in a rapidly changing future by helping them find answers in large amounts of data that they can't otherwise see. Our algorithms help customers see the big picture in scattered data by revealing unknown connections and even explaining why they exist. 100% own IP, combines the strengths of Natural LanguageProcessing, self-organized learning, reinforcement learning and 20+ years experience on cognitive sciences.
- SET Ventures — SET propels founders from early growth to European scale. We invest in and grow the solutions powering the digital energy economy.
Stefan Lindberg is co-owner of YSUB.
Show more...Investment focus
- Industry: Wellness, Nutrition, Fruit
- Stage:Pre-Seed, Seed, Angel
- Geography: Finland
Investor stats
- Total investments: 6
- Round size: Seed $296k–$430k; Pre-Seed $179k–$549k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Vegemi — Vegemi is a free smartphone app that promotes eating fruits and vegetables through gaming. The software was designed with the entire family in mind, but especially to demonstrate youngsters the health advantages of fruits and vegetables in a way that motivates and inspires them.
- sommify — Catalogue in, curated offer out. sommify pairs your wines to a restaurant's menu, prices every pour, and exports a beautiful branded document.
- StepOut.pro — A digital platform for fitness & wellness freelancers to streamline their business activities
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 407
- Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $30M–$118M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- IVERIC bio — IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inheritedretinal diseases.
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Singapore, Australia
Investor stats
- Total investments: 2382
- Round size: Seed $158k–$4.6M; Pre-Seed $100k–$600k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026
Portfolio highlights
- Obud — Obud is a wellness reservation systems that is designed for holistic health and lifestyle management purposes. The company's systems offer a comprehensive suite of tools for booking wellness activities, managing schedules, and accessing curated wellness programs, enabling wellness centers to streamline their operations, enhance userengagement, and promote a balanced and healthy lifestyle.
- myluigi.ai — Luigi is an AI-Powered Full-Stack Game Growth-as-a-Service platform designed to help mobile game studios scale user acquisition, engagement and lifetime value without adding headcount. Its dual-engine architecture automates and operates everything from ad campaign creation and real-time creative optimization to personalized in-game offers and LTVforecasting—delivered through a single, easy-to-integrate and unified dashboard. With a flexible per-title pricing model and powerful machine-learning insights, Luigi empowers mid-sized and indie developers to reduce CPI, boost retention and chart a clear path toward sustainable growth and seven-figure ARR.
- RubiLabs — RubiLabs Inc provides a platform for unifying, monitoring, and analyzing organizational data. RubiLabs software enables analysts and operators across risk, compliance, and security teams to collaborate and interpret large volumes of information in real time. The company’s platform is designed to help institutions make sense of complex, fragmenteddata by transforming it into a coherent operational picture for risk detection, continuous monitoring, and investigative workflows.
We partner with deep tech and brand-driven companies obsessed in challenging category norms. The Nordics are our home, but we take on a global front in spotting the unexpected - from B2B to B2C, with a sweet spot for scientific advances, strong IP, and customer understanding that looks beyond convention.We invest in early stage companies: fromtheir inception to series A and beyond. We share in the vision of founders as champions and challengers, drawing on our experiences from scaling some of the strongest tech companies ourselves.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, Norway, Denmark
Investor stats
- Total investments: 103
- Round size: Seed $948k–$8.3M; Pre-Seed $578k–$2.7M; Series A $3.5M–$37M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $106M in 2024
Portfolio highlights
- Aavuus — Aavuus is building a global network of ground-based laser stations to detect and track space debris with high precision.
- Metaktik — Tactical Metasurface Antenna Solution for Defence. Ultralight Antennas for Satellites.
- Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
Some call you founders. We call you Superheroes. Seed stage VC investing in insight-driven startups in Finland and the Baltics. Tickets 100 K€ - 1000 K€.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Finland, Lithuania, Estonia
Investor stats
- Total investments: 103
- Round size: Seed $228k–$2.6M; Pre-Seed $114k–$1.8M; Venture - Series Unknown $1.6M–$7.3M
- Lead/follow: 56% lead, 44% follow
- Last fund: Likely actively investing — fresh fund, raised $41M in 2025
Portfolio highlights
- Bilt.me — Describe your app idea and Bilt builds it. Preview on your phone, publish to the App or Play Store when you're ready.
- Guideless — Guideless turns any browser workflow into a polished, AI-narrated video guide in minutes. No screen recording, no tedious editing. Just turn on our Chrome extension, click through your process as you normally would, and instantly get a share-ready guide.Use cases: Product walkthroughs, customer onboarding, employee training, and supportdocumentation.Key features: - AI-written narration and natural voiceover. - Smart zooms and highlights for clarity. - Built-in captions for accessibility. - Always consistent and on-brand. - Shareable URLs, embed codes, and export to MP4How it works: - Add the Chrome extension. - Capture your workflow. - Share your guide.Privacy built-in: Your guides and data are never used to train AI models and are securely encrypted.Check https://guideless.ai/gallery and get inspired with curated guides showcasing workflows, product demos, and tutorials across every use case.
- SeeTrue Technologies — Ultra-low-power eye tracking from SeeTrue delivers accurate gaze data for AR/VR, microscope & camera eyepieces and wearables, powered by custom sensors.
Oy Hammaren & Co Ab provides financial services and insurance activities.
Show more...Investment focus
- Industry: Health Care, Wellness, GreenTech
- Stage:Venture - Series Unknown, Angel, Series A
- Geography: Finland
Investor stats
- Total investments: 4
- Round size: Venture - Series Unknown $1.5M–$7.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- Heltti — Heltti redefines occupational healthcare and well-being services with technology and a subscription model. Heltti develops the most lovable digital health care systems. Heltti is a Finnish occupational health care company founded in 2013. It is owned by its employees and a handful of renowned Finnish investors, such as Risto Siilasmaa.
- NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 234
- Round size: Series A $5.1M–$81M; Series B $11M–$107M; Series C $9M–$75M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $200M in 2009
Portfolio highlights
- Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
- Visiogen — Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions.The device isdesigned to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
- Rein Therapeutics — Rein Therapeutics is advancing a novel pipeline of first-in-class medicines to address unmet medical needs in orphan pulmonary and fibrosis indications.
Johannes Schildt, a true serial entrepreneur who founded or co-founded more than 3 companies, started his first company while still in school. Schildt later made a meteoric career at Stardoll working alongside people like Henrik Torstensson & Marcus Gners. Johannes successfully launched Stardoll's first official Facebook game, reaching1,000,000 monthly unique users within 3 months after launch. Today, Johannes is the CEO & Co-founder of Kry. By combining new technology with leading medical expertise KRY has built a platform to make healthcare digital.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Sweden, Finland, United States
Investor stats
- Total investments: 14
- Round size: Seed $2.8M–$4.4M; Pre-Seed $641k–$4M; Series A $17M–$18M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Noru — Noru automates GDPR Article 30 data discovery and compliance controls, giving enterprises continuous, verifiable proof of their privacy and security posture.
- Cerrion — Cerrion is a visual AI that helps production teams react faster to process deviations, automate root cause analysis, and implement targeted improvement actions. They believe that process transparency enabled by AI and computer vision is key to achieving more autonomy and sustainability in manufacturing. Their software is built and designed withproduction teams from all over the world in the loop.
- Fika Jobs — Stand out from the crowd. Find your perfect job.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Elias Aalto is Wolt's Advisor and a Co-Founder before that.
Show more...Investment focus
- Industry: Internet, Health Care, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Estonia
Investor stats
- Total investments: 11
- Round size: Seed $430k–$10M; Pre-Seed $525k–$799k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cluby — Cluby is a technology platform that provides restaurants with the best tools for managing and communicating with loyal consumers.
- Flowstep — Flowstep is a copilot that helps you create better designs, 10x faster. Just type and get user flows, high-fidelity UI, JTBD and more.
- Operating — Operating is a SaaS platform for resource management, project staffing, time tracking, and capacity forecasting for consulting and professional services teams.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 188
- Round size: Seed $2.4M–$24M; Series A $5.8M–$50M; Series B $13M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
- TwoStep Therapeutics — TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
- Polaris Electro-Optics — Polaris Electro-Optics empowers integrated photonics for communications and computation.
96 Normal 0 false false false EN-GB X-NONE X-NONE
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: Germany, Finland, The Netherlands
Investor stats
- Total investments: 13
- Round size: Series A $2M–$7.9M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Fiagon — Fiagon develops clinical navigation systems that reimagine image guidance by improving the function of electromagnetic navigation. Fiagon's systems use electromagnetic tracking matrix algorithms and flexible pointer technology that indicates the position of the instrument used in the CT or MRI image data, allowing physicians to get accurateplanning, improve patient outcomes, and implementation of the operation.
- Meidrix Biomedicals — Meidrix Biomedicals is a medical biotechnology company that specializes in medical devices for cartilage repair. Meidrix Biomedicals also offers regenerative and biological medical products. Meidrix Biomedicals was founded in 2009 and was headquartered in Bayern, Germany.
- SurgicEye — SurgicEye designs intra-operative imaging and instrument navigation solutions for surgical procedures. It offers a navigated radio-guided surgery based on the handheld 3-D freehand SPECT imaging technology called the declipse SPECT open surgery, an intraoperative 3D imaging system for invasive sentinel lymph node biopsy called the declipse SPECTLaparascopy, and a mobile SPECT imaging solution with a high resolution on a small footprint called the declipse SPECT imaging probe. The company also advises clients on medical device development, requirement engineering and software specification for medical devices, software development for medical devices, testing of software for medical devices, and support in the design and conduction of clinical studies.Dr. Jörg Traub founded SurgicEye in 2008, with its headquarters in Munich in Germany.
Investment focus
- Industry: Manufacturing, Software, Biotechnology
- Stage:Grant, Venture - Series Unknown, Seed
- Geography: Spain, Italy, United Kingdom
Investor stats
- Total investments: 3533
- Round size: Seed $53k–$800k; Grant $54k–$2M; Venture - Series Unknown $573k–$2.6M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
- Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
Gorilla Capital helps ambitious startups grow with smart funding and support. Discover how our team invests in early-stage companies.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Pre-Seed, Seed, Venture - Series Unknown
- Geography: Finland, Sweden, Estonia
Investor stats
- Total investments: 79
- Round size: Seed $294k–$1.5M; Pre-Seed $149k–$680k; Venture - Series Unknown $1.1M–$2.1M
- Lead/follow: 66% lead, 34% follow
- Last fund: Likely actively investing — fresh fund, raised $49M in 2025
Portfolio highlights
- Munchi — Munchi allows restaurants to manage all orders, payments and loyalty in one platform with the power of AI.
- Amplifiles — Amplifiles is a PropTech startup that turns real estate listing photos into fully branded, high-quality videos in minute, no filming or editing required. Our video engine helps agents, photographers, and marketplaces boost engagement, generate more leads, and unlock new revenue streams.
- Nordic Information Control — Inventering och klassificering av information, automatiskt med Nordic Information Control Platform. Automatic Regulatory compliance.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Venture - Series Unknown, Seed
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 32
- Round size: Venture - Series Unknown $3.2M–$10M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- BOOST Pharma — BOOST Pharma is developing BT-101, an off-the-shelf therapy for early intervention in children with severe osteogenesis imperfecta (OI).
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
- Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Healthcare business development, management, and investing. Very good knowledge on healthcare services and public health. Kustaa Piha is interested in new business and investment opportunities and better ways of producing excellent healthcare services.
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Medical Device
- Stage:Seed, Venture - Series Unknown
- Geography: Finland
Investor stats
- Total investments: 5
- Round size: Seed $537k–$1.3M
- Lead/follow: 80% lead, 20% follow
Portfolio highlights
- Sooma — Sooma provides unique therapy solutions that combine effectiveness with ease-of-use. Therapies are based on tDCS method.
- Klinik — Klinik® is an innovative health website designed from the very beginning to meet the needs of users. They offer advanced tools for consumers to identify their conditions and to treat them properly, and if needed, they connect them with matching health professionals. It’s a unique platform for health experts to show their true expertise toconsumers. Main characteristics of their offering are:1) Easy access to qualified and reliable health and medical information2) Helping people to identify their conditions3) Providing people valid evidence-based info on self care4) Integrating professional healthcare providers with users requesting additional medical.
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
The Pharmacy Pension Fund offers insurance services. Their services include employment pension statement, secure message, applying for a pension, insurance matters, pensioner and beneficiary services, vocational rehabilitation travel reimbursement application, and certificate of pension.
Show more...Investment focus
- Industry: Health Care
- Stage:Venture - Series Unknown
- Geography: Finland
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Nukute — Nukute is a medical device and services development company that intends to design, patent, and market medical devices and services related to sleep apnea. The company's sleep apnea screening and diagnostics solution includes two wireless wearable sensors, a tablet computer, and a cloud application. Wearable sensors record biosignals such asbreathing, blood oxygen saturation, heart rate and sleeping position to be analyzed in the cloud using a machine learning algorithm.Nukute was established in 2015 and is headquartered in Oulu, Finland.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
- Koite Health — Koite Health develops medical equipment using antimicrobial photodynamic treatment. It is a health technology firm that pioneered the creation of light-activated antibacterial treatments and preventative measures for oral ailments. It uses LED lighting technology with the light-activated, antibacterial lumorinse mouthwash.
Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.
Show more...Investment focus
- Industry: Apps, Mobile, Content
- Stage:Venture - Series Unknown, Seed
- Geography: Finland, Estonia
Investor stats
- Total investments: 5
- Round size: Venture - Series Unknown $6.3M–$16M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Hintsa — Discover a better you, with methods proven in Formula 1 and Fortune 500.
- R8tech — R8 Jenny is AI HVAC technology for commercial real estate. It helps you achieve ESG goals while saving up to 30% in energy costs!
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Energy, Health Care
- Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
- Geography: France, Germany, Spain
Investor stats
- Total investments: 595
- Round size: Post-IPO Debt $18M–$587M; Debt Financing $16M–$355M; Venture - Series Unknown $8.7M–$90M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- VaxThera — VaxThera develops and produces vaccines to prevents and treats diseases.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
- Reactive Technologies — Reactive Technologies we are committed to enabling a more intelligent use of energy, for the largest and most complex business to the smallest household. Our aim is to develop new technologies that will positively assist the energy industry to deliver cleaner, greener and more affordable energy, through more efficient and effective energymanagement and control. Through our innovative, cloud-based solution for Corporate customers – Tradenergy® – we have begun this process and with our pipeline of ground breaking new technologies we intend to continue.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jyri Engeström is an Investor and Partner of Yes VC. He attended Lancaster University
Show more...Investment focus
- Industry: Software, Apps, Internet
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Finland, Spain
Investor stats
- Total investments: 37
- Round size: Seed $600k–$4.7M; Pre-Seed $3M–$5.5M; Series A $2.8M–$20M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Jow — Jow is a grocery shopping app that simplifies shopping and gives advice of what to eat. This app offers free and simple recipes that adapt to the customer's taste. It automatically creates a customized menu with delicious recipes and fills the cart with all the ingredients necessary for cooking.Jow was founded in 2017 and is headquartered inParis, France.
- Spell — Operationalizing AI for NLP, Computer Vision, and Speech Recognition has never been easier
- Orchid Labs — Orchid Labs is an open-source project committed to ending surveillance and censorship on the internet. Orchid uses an overlay network built upon the existing internet, which is driven by a peer-to-peer tokenized bandwidth exchange, creating a more inclusive, liberated internet. Orchid Labs was founded in 2017 by Dr. Steven Waterhouse, Jay Freeman,Brian J. Fox, Gustav Simonsson, and Stephen Bell.
cross-border, healthcare, life science, investment, VC, China, US
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Finland, United States
Investor stats
- Total investments: 5
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Marginum — Pioneering the next-generation quantitative surgical techniques.
- Elucida Oncology — Elucida Oncology focuses on transforming outcomes for patients with primary solid tumors and metastatic cancer. The company utilizes the novel target or clear capabilities of its ultra-small C-Dot cancer-targeting particle platform across diagnostic imaging, surgical, and a wide range of therapeutic applications.
- Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.
Athensmed Oy
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Medical
- Stage:Seed, Series A
- Geography: Finland, Switzerland
Investor stats
- Total investments: 5
- Round size: Seed $1.1M–$4.3M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Biospectal — Measure and track blood pressure with only your phone camera and fingertip. With OptIBP, you can keep a diary of blood pressure, share BP, and take control of your heart health.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
First Fellow Partners is a private investment firm built on a founder-first philosophy. We invest only our own capital, backing bold, mission-driven technology entrepreneurs from idea to lasting impact.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, United States, Sweden
Investor stats
- Total investments: 76
- Round size: Seed $500k–$8M; Pre-Seed $256k–$1.7M; Series A $2.3M–$26M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- CRACI — CRACI automates the compliance requirements of the EU CRA for product and service companies. The platform secures software supply chains from attacks.
- Endform — Run your Playwright tests faster with https://t.co/FYIS1dSPdF
- Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 6
- Round size: Seed $2.3M–$8.7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Gosta Labs — Focus on care
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
- Nightingale Health — The most advanced health check for the health industry.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 141
- Round size: Series A $6M–$73M; Series B $12M–$92M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $179M in 2024
Portfolio highlights
- Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
- AMRA Medical — AMRA Medical is a digital health company transforming medical research and clinical care using rapid whole-body MRI technology.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Nostetta Ventures is a venture capital company investing in growth companies mainly in the North Savo region.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Finland
Investor stats
- Total investments: 3
- Round size: Seed $1.1M–$2.9M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Marginum — Pioneering the next-generation quantitative surgical techniques.
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 97
- Round size: Seed $1.1M–$7.7M; Series A $2M–$12M; Series B $5.1M–$30M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $90M in 2016
Portfolio highlights
- HeyJobs — Intelligent recruiting | more hires with performance marketing | only qualified candidates | fast recruiting success | over 1,500 companies use HeyJobs to find employees
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- Chundsell Medicals — Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. TheProstatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.
Alliance Venture is a Nordic venture capital firm investing in exceptional early-stage tech companies and purpose-driven founders with global ambitions. Offices in Oslo, Stockholm, Copenhagen and Helsinki.
Show more...Investment focus
- Industry: Software, Information Technology, Analytics
- Stage:Seed, Series A, Pre-Seed
- Geography: Norway, United States, Sweden
Investor stats
- Total investments: 83
- Round size: Seed $1.3M–$5M; Pre-Seed $1M–$4M; Series A $1.8M–$19M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Fika Jobs — is building a video-first hiring platform that combines AI interview agents with short-form video profiles.
- Newcode.ai —
- Lightbringer — Experience the future of patent services with Lightbringer. Our AI-driven platform accelerates your patent process, ensuring efficiency and expertise from world-class patent attorneys.
Metsola Ventures
Show more...Investment focus
- Industry: Medical, mHealth, Health Care
- Stage:Series A
- Geography: Finland
Investor stats
- Total investments: 2
- Round size: Series A $2.2M–$4.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Health Care Investor funding in Finland at a glance
Stats across 472 deals from 423 investors.
Access all 423 investors in Finland Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care Investors in Finland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 423 investors investing in Finland Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!